Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

MALT1 promotes melanoma progression through JNK/c-Jun signaling.

Wang Y, Zhang G, Jin J, Degan S, Tameze Y, Zhang JY.

Oncogenesis. 2017 Jul 31;6(7):e365. doi: 10.1038/oncsis.2017.68.

2.

Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis.

Macias-Ceja DC, Cosín-Roger J, Ortiz-Masiá D, Salvador P, Hernández C, Esplugues JV, Calatayud S, Barrachina MD.

Br J Pharmacol. 2017 Aug;174(15):2501-2511. doi: 10.1111/bph.13860. Epub 2017 Jun 21.

PMID:
28500644
4.

NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20.

Drennan MB, Govindarajan S, Verheugen E, Coquet JM, Staal J, McGuire C, Taghon T, Leclercq G, Beyaert R, van Loo G, Lambrecht BN, Elewaut D.

J Exp Med. 2016 Sep 19;213(10):1973-81. doi: 10.1084/jem.20151065. Epub 2016 Aug 22.

5.

Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.

Jattani RP, Tritapoe JM, Pomerantz JL.

J Biol Chem. 2016 Apr 15;291(16):8338-48. doi: 10.1074/jbc.M116.717322. Epub 2016 Feb 16.

6.

The paracaspase MALT1: biological function and potential for therapeutic inhibition.

Jaworski M, Thome M.

Cell Mol Life Sci. 2016 Feb;73(3):459-73. doi: 10.1007/s00018-015-2059-z. Epub 2015 Oct 27. Review.

7.

Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation.

Satpathy S, Wagner SA, Beli P, Gupta R, Kristiansen TA, Malinova D, Francavilla C, Tolar P, Bishop GA, Hostager BS, Choudhary C.

Mol Syst Biol. 2015 Jun 2;11(6):810. doi: 10.15252/msb.20145880.

8.

MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.

Yu JW, Hoffman S, Beal AM, Dykon A, Ringenberg MA, Hughes AC, Dare L, Anderson AD, Finger J, Kasparcova V, Rickard D, Berger SB, Ramanjulu J, Emery JG, Gough PJ, Bertin J, Foley KP.

PLoS One. 2015 May 12;10(5):e0127083. doi: 10.1371/journal.pone.0127083. eCollection 2015.

9.

MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation.

Karim ZA, Vemana HP, Khasawneh FT.

PLoS One. 2015 Mar 6;10(3):e0119363. doi: 10.1371/journal.pone.0119363. eCollection 2015.

10.

Protein ubiquitination in lymphoid malignancies.

Yang Y, Staudt LM.

Immunol Rev. 2015 Jan;263(1):240-56. doi: 10.1111/imr.12247. Review.

11.

MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.

Baens M, Bonsignore L, Somers R, Vanderheydt C, Weeks SD, Gunnarsson J, Nilsson E, Roth RG, Thome M, Marynen P.

PLoS One. 2014 Aug 8;9(8):e103774. doi: 10.1371/journal.pone.0103774. eCollection 2014.

12.

T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.

Hamilton KS, Phong B, Corey C, Cheng J, Gorentla B, Zhong X, Shiva S, Kane LP.

Sci Signal. 2014 Jun 10;7(329):ra55. doi: 10.1126/scisignal.2005169.

13.

BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response.

Zhao H, Zhu M, Dou G, Zhao H, Zhu B, Li J, Liao J, Xu X.

Cell Cycle. 2014;13(11):1777-87. doi: 10.4161/cc.28707. Epub 2014 Apr 14.

14.

The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Yang C, David L, Qiao Q, Damko E, Wu H.

Cytokine Growth Factor Rev. 2014 Apr;25(2):175-83. doi: 10.1016/j.cytogfr.2013.12.008. Epub 2013 Dec 24. Review.

15.

Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells.

Munitic I, Giardino Torchia ML, Meena NP, Zhu G, Li CC, Ashwell JD.

J Immunol. 2013 Dec 15;191(12):6231-40. doi: 10.4049/jimmunol.1301696. Epub 2013 Nov 15.

16.

Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.

Cabalzar K, Pelzer C, Wolf A, Lenz G, Iwaszkiewicz J, Zoete V, Hailfinger S, Thome M.

PLoS One. 2013 Aug 19;8(8):e72051. doi: 10.1371/journal.pone.0072051. eCollection 2013.

17.

Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.

Park Y, Jin HS, Liu YC.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9433-8. doi: 10.1073/pnas.1221925110. Epub 2013 May 20.

18.

Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34.

Poalas K, Hatchi EM, Cordeiro N, Dubois SM, Leclair HM, Leveau C, Alexia C, Gavard J, Vazquez A, Bidère N.

Cell Commun Signal. 2013 Apr 16;11(1):25. doi: 10.1186/1478-811X-11-25.

19.

A new look at T cell receptor signaling to nuclear factor-κB.

Paul S, Schaefer BC.

Trends Immunol. 2013 Jun;34(6):269-81. doi: 10.1016/j.it.2013.02.002. Epub 2013 Mar 7. Review.

20.

Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.

Moreno-García ME, Sommer K, Rincon-Arano H, Brault M, Ninomiya-Tsuji J, Matesic LE, Rawlings DJ.

Mol Cell Biol. 2013 Mar;33(6):1149-63. doi: 10.1128/MCB.06407-11. Epub 2013 Jan 7.

Supplemental Content

Support Center